[Form 4] STAAR SURGICAL CO Insider Trading Activity

Rhea-AI Filing Summary

Broadwood Partners, L.P. and related parties reported open-market purchases of STAAR Surgical (STAA) common stock. On 11/19/2025, they purchased 309,132 shares at a weighted average price of $26.4164. On 11/20/2025, they purchased 393,382 shares at a weighted average price of $27.1373, and on 11/21/2025 they purchased 797,486 shares at a weighted average price of $27.8611.

Following these transactions, Broadwood Partners directly beneficially owned 15,019,491 shares of common stock, and 25,900 shares were directly owned by Neal C. Bradsher. The reporting persons include Broadwood Partners, L.P., Broadwood Capital, Inc. and Neal C. Bradsher, who is identified as a director and 10% owner. The parties state that each disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest.

Insights

Equity Ownership and Governance Analyst

Large insider group increased stake via open-market purchases, signaling stronger economic alignment with the issuer.

The filing shows **Broadwood Partners, L.P.** and related entities purchasing common stock of **STAAR Surgical Co.** on three consecutive days, from 11/19/2025 to 11/21/2025. Reported purchases total several hundred thousand shares per day at weighted average prices of about $26.42, $27.14, and $27.86, within the disclosed price ranges. After these transactions, the reporting group reports beneficial ownership of **15,019,491** shares, with most held through Broadwood Partners and **25,900** shares held directly by **Neal C. Bradsher**.

The structure matters. The securities are directly owned by Broadwood Partners, and may be deemed indirectly owned by **Broadwood Capital, Inc.** as general partner and by Bradsher as president of Broadwood Capital, each expressly limiting beneficial ownership to their economic interest. This reflects a typical fund/general-partner/individual control chain, and confirms that the reporting persons are both **directors** and **10% owners**, which ties governance influence to a sizable equity position.

From a monitoring standpoint, the key facts are: (i) open-market **purchases (transaction code P)**, not sales; (ii) a step-up in aggregate ownership to over fifteen million shares by 11/21/2025; and (iii) use of weighted-average price disclosure with an undertaking to provide detailed trade breakdowns upon request. Future Forms 4 from this group will show whether this is a one-time accumulation or part of an ongoing buying pattern, which may affect perceptions of their long-term commitment and governance role.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/19/2025		P		309,132	A	$26.4164(2)	13,828,623	D(1)
Common Stock	11/19/2025		P		0	A	$0	13,828,623	I	Footnote(1)
Common Stock	11/20/2025		P		393,382	A	$27.1373(3)	14,222,005	D(1)
Common Stock	11/20/2025		P		0	A	$0	14,222,005	I	Footnote(1)
Common Stock	11/21/2025		P		797,486	A	$27.8611(4)	15,019,491	D(1)
Common Stock	11/21/2025		P		0	A	$0	15,019,491	I	Footnote(1)
Common Stock								25,900	D(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

BROADWOOD PARTNERS, L.P.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BROADWOOD CAPITAL INC

(Last) (First) (Middle)

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Bradsher Neal C

(Last) (First) (Middle)

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital") as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher as President of Broadwood Capital. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

2. This constitutes the weighted average purchase price. The prices range from $25.60 to $26.50. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

3. This constitutes the weighted average purchase price. The prices range from $26.56 to $27.35. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

4. This constitutes the weighted average purchase price. The prices range from $27.30 to $28.23. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

5. These securities are directly owned by Neal C. Bradsher.

	Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	11/21/2025
	Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	11/21/2025
	Neal C. Bradsher, /s/ Neal C. Bradsher	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did STAAR Surgical (STAA) report on this Form 4?

The filing reports that Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher acquired STAAR Surgical common stock in open-market purchases on 11/19/2025, 11/20/2025, and 11/21/2025.

How many STAAR Surgical (STAA) shares were purchased on each reported date?

The reporting persons purchased 309,132 shares on 11/19/2025, 393,382 shares on 11/20/2025, and 797,486 shares on 11/21/2025.

At what prices were the STAAR Surgical (STAA) shares acquired?

The purchases were made at weighted average prices of $26.4164 on 11/19/2025, $27.1373 on 11/20/2025, and $27.8611 on 11/21/2025, with price ranges disclosed for each day.

What is the total STAAR Surgical (STAA) stake reported after these transactions?

After the reported transactions, Broadwood Partners directly beneficially owned 15,019,491 shares of STAAR Surgical common stock, and 25,900 shares were directly owned by Neal C. Bradsher.

Who are the reporting persons in this STAAR Surgical (STAA) Form 4?

The reporting persons are Broadwood Partners, L.P., Broadwood Capital, Inc. (its General Partner), and Neal C. Bradsher, who is identified as a director and 10% owner of STAAR Surgical.

Do the reporting persons claim full beneficial ownership of all reported STAAR Surgical shares?

No. The filing states that each reporting person may be deemed to beneficially own the securities but disclaims beneficial ownership except to the extent of its or his pecuniary interest.